Delivery Order SPE2DB24D2100-SPE2DB25FBBAB

Award Date 11/22/24
Potential Completion Date 12/16/24
Potential Value $33K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,903.03, is for the delivery of the prescription medication Tagrisso 80 mg tablets. It is a firm fixed-price delivery order contract with a completion date of December 16, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Tagrisso 80 mg tablets. The contract has a ceiling value of $31,616.37 and a period of performance through June 7, 2024. It is a firm fixed-price delivery order contract, with no set-aside designation indicated. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,538.79 firm fixed-price contract is for the supply of TAGRISSO 80 MG TABLET 30S, a prescription medication. The contract has a period of performance ending on December 2, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $21,325.14 contract is for the delivery of TAGRISSO 80 MG TABLET 30S, a specialty medication, with a period of performance through February 26, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999, to provide a broad range of pharmaceutical products and medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation for the supply of the pharmaceutical product Tagrisso 80 mg tablet in quantities of 30. The contract has a ceiling value of $63,141.30 and is a firm-fixed price contract. It has an ultimate completion date of October 21, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with various...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,662.57, is for the delivery of Tagrisso 80 mg tablets, a medication used in cancer treatment. The contract has a firm fixed price and an ultimate completion date of February 4, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a $42,607.28 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tagrisso 80 mg tablets, a cancer medication, with a period of performance through July 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $21,077.60 firm fixed price contract is for the supply of Tagrisso 80 mg tablets, a specialty oncology medication. This delivery order falls under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which enables the government to efficiently procure a wide range of...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Tagrisso 80 mg tablets, with a ceiling value of $42,650.28 and a period of performance through July 21, 2025. The contract is not set-aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the cancer medication Tagrisso 40 mg tablets. The $21,016.64 firm fixed-price contract has an ultimate completion date of August 9, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for delivering a comprehensive range of medical...
  • SPE2DB24D2100
    Indefinite Delivery Contract
  • SPE2DB24D2100-SPE2DB25FBBAB
    Delivery Order

This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Tagrisso 80 mg tablets, a specialty medication. The contract has a firm fixed price of $32,709.09 and a completion date of December 16, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award was not designated with a set-aside requirement, indicating open competition.

Generated 2/21/25, 9:13 AM